Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Cholangiocarcinoma Heterogeneity Revealed by Multigene Mutational Profiling: Clinical and Prognostic Relevance in Surgically Resected Patients
Ist Teil von
Annals of surgical oncology, 2016-05, Vol.23 (5), p.1699-1707
Ort / Verlag
Cham: Springer International Publishing
Erscheinungsjahr
2016
Quelle
MEDLINE
Beschreibungen/Notizen
Background
Cholangiocarcinoma can be classified in intrahepatic cholangiocarcinoma (ICC) and perihilar cholangiocarcinoma (PCC). Moreover, PCC includes two different forms: extrahepatic (EH) PCC, which arises from the perihilar EH large ducts, and intrahepatic (IH) PCC, in which a significant liver mass invades the perihilar bile ducts. In this study, we investigated the molecular profile and molecular prognostic factors in EH-PCC, IH-PCC, and ICC submitted to curative surgery.
Methods
Ninety-one patients with cholangiocarcinoma (38 EH-PCC, 18 IH-PCC, and 35 ICC), who underwent curative surgery in a single tertiary hepatobiliary surgery referral center were assessed for mutational status in 56 cancer-related genes.
Results
The most frequently mutated genes in EH-PCC were
KRAS
(47.4 %),
TP53
(23.7 %) and
ARID1A
(15.8 %); in IH-PCC were
KRAS
(22.2 %),
PBRM1
(16.7 %), and
PIK3CA
(16.7 %); and in ICC were
IDH1
(17.1 %),
NRAS
(17.1 %), and
BAP1
(14.3 %). The presence of mutations in
ALK
,
IDH1
, and
TP53
genes was significantly associated with poor prognosis in patients with EH-PCC (
p
< 0.001,
p
= 0.043, and
p
= 0.019, respectively). Mutation of the
TP53
gene was significantly associated with poor prognosis in patients with IH-PCC (
p
= 0.049). The presence of mutations in
ARID1A
,
PIK3C2G
,
STK11
,
TGFBR2
, and
TP53
genes was significantly associated with poor prognosis in patients with ICC (
p
= 0.012,
p
= 0.030,
p
= 0.030,
p
= 0.011, and
p
= 0.011, respectively).
Conclusions
Mutational gene profiling identified different gene mutations in EH-PCC, IH-PCC, and ICC. Moreover, our study reported specific prognostic genes that can identify patients with poor prognosis after curative surgery who may benefit from traditional or target adjuvant treatments.